Davide Ruggero
University of California, San Francisco
H-index: 54
North America-United States
Top articles of Davide Ruggero
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
miR-217 regulates normal and tumor cell fate following induction of Endoplasmic Reticulum Stress | Molecular Cancer Research | Neekkan Dey Costas Koumenis Davide Ruggero Serge Y Fuchs J Alan Diehl | 2024/2/14 |
Evolutionarily divergent mTOR remodels translatome for tissue regeneration | Nature | Olena Zhulyn Hannah D Rosenblatt Leila Shokat Shizhong Dai Duygu Kuzuoglu-Öztürk | 2023/8/3 |
Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates | Elife | Adele Francis Xu Rut Molinuevo Elisa Fazzari Harrison Tom Zijian Zhang | 2023/6/12 |
Elongation factor 1-alpha inhibitors and uses thereof | 2023/5/4 | ||
N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma | Cancer research | Duygu Kuzuoglu-Ozturk Ozlem Aksoy Christin Schmidt Robin Lea Jon D Larson | 2023/1/4 |
AR inhibition increases MHC class I expression and improves immune response in prostate cancer | Lisa N Chesner Julie N Graff Fanny Polesso Alexis Smith Arian Lundberg | 2023 | |
RAPIDASH: A tag-free enrichment of ribosome-associated proteins reveals compositional dynamics in embryonic tissues and stimulated macrophages | bioRxiv | Teodorus Theo Susanto Victoria Hung Andrew G Levine Craig H Kerr Yongjin Yoo | 2023/12/7 |
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer | Nature Communications | Irati Macaya Marta Roman Connor Welch Rodrigo Entrialgo-Cadierno Marina Salmon | 2023/10/10 |
Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3 | Nature chemistry | Hao-Yuan Wang Haojun Yang Mikael Holm Harrison Tom Keely Oltion | 2022/12 |
A tRF nucleator for Nucleolin in cancer metastasis | Molecular Cell | Yichen Xu Davide Ruggero | 2022/7/21 |
Localization of a TORC1-eIF4F translation complex during CD8+ T cell activation drives divergent cell fate | Molecular cell | Swantje Liedmann Xueyan Liu Clifford S Guy Jeremy Chase Crawford Diego A Rodriguez | 2022/7/7 |
Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress | 2022/5/19 | ||
Protein synthesis control in cancer: selectivity and therapeutic targeting | Joanna R Kovalski Duygu Kuzuoglu‐Ozturk Davide Ruggero | 2022/4/19 | |
Regulation of eIF4E guides a unique translational program to control erythroid maturation | Science Advances | Craig M Forester Juan A Oses-Prieto Nancy J Phillips Sohit Miglani Xiaming Pang | 2022/12/23 |
Examining Myc-dependent translation changes in cellular homeostasis and cancer | Joanna R Kovalski Yichen Xu Davide Ruggero | 2021/5/22 | |
A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies | Developmental cell | Gerald C Tiu Craig H Kerr Craig M Forester Pallavi S Krishnarao Hannah D Rosenblatt | 2021/7/26 |
Ferronostics: a next gen theranostic strategy to identify diseases susceptible treatment with therapies targeting the labile iron pool. | Michael Evans Ning Zhao Yung-Hua Wang Adam Renslo Youngho Seo | 2021/5/1 | |
Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function | Iscience | Honyin Chiu Roberta Buono Leandra V Jackson Lee-or Herzog Sharmila Mallya | 2021/7/23 |
The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity | Nature metabolism | Crystal S Conn Haojun Yang Harrison J Tom Kenji Ikeda Juan A Oses-Prieto | 2021/2 |
Releasing the brake on protein synthesis in hematopoietic stem cells | Cell Stem Cell | Craig M Forester Davide Ruggero | 2021/7/1 |